Cargando…
Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241177/ https://www.ncbi.nlm.nih.gov/pubmed/35768868 http://dx.doi.org/10.1186/s12943-022-01609-6 |
| _version_ | 1784737739767283712 |
|---|---|
| author | Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli |
| author_facet | Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli |
| author_sort | Dong, Huaying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9241177 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92411772022-06-30 Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli Mol Cancer Retraction Note BioMed Central 2022-06-29 /pmc/articles/PMC9241177/ /pubmed/35768868 http://dx.doi.org/10.1186/s12943-022-01609-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Dong, Huaying Hu, Jianguo Zou, Kejian Ye, Mulin Chen, Yuanwen Wu, Chengyi Chen, Xin Han, Mingli Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title | Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_full | Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_fullStr | Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_full_unstemmed | Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_short | Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer |
| title_sort | retraction note to: activation of lncrna tincr by h3k27 acetylation promotes trastuzumab resistance and epithelial-mesenchymal transition by targeting microrna-125b in breast cancer |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241177/ https://www.ncbi.nlm.nih.gov/pubmed/35768868 http://dx.doi.org/10.1186/s12943-022-01609-6 |
| work_keys_str_mv | AT donghuaying retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT hujianguo retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT zoukejian retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT yemulin retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT chenyuanwen retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT wuchengyi retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT chenxin retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer AT hanmingli retractionnotetoactivationoflncrnatincrbyh3k27acetylationpromotestrastuzumabresistanceandepithelialmesenchymaltransitionbytargetingmicrorna125binbreastcancer |